Bausch + Lomb Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bausch + Lomb Corporation on August 14, 2025. The filing addresses corporate governance changes resulting from the termination of a material definitive agreement with the Icahn Group.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and legal agreements rather than financial performance.
Material Changes
- Termination of Agreement: The Amended and Restated Director Appointment and Nomination Agreement with the Icahn Group terminated effective August 14, 2025. This occurred because the Icahn Group's net long position in Bausch Health Companies Inc. fell below the required threshold.
- Board Resignations: Brett Icahn and Gary Hu resigned from the Board of Directors effective August 14, 2025. Both were appointees of the Icahn Group since June 2022.
- Committee Impact: Gary Hu served on the Audit and Risk Committee, the Talent and Compensation Committee, and the Science and Technology Committee until his resignation.
Guidance, Outlook, and Risks
Management stated that the resignations did not result from any disagreement with Bausch + Lomb. A press release detailing these updates was issued on August 18, 2025, and is included as Exhibit 99.1. The filing does not contain specific financial guidance, outlook, or new risk factors beyond the governance changes described.
Investor Verification Checklist
- Verify the current board composition following the resignations of Brett Icahn and Gary Hu.
- Confirm the Icahn Group's current ownership stake in Bausch Health Companies Inc. to understand the trigger for the agreement termination.
- Review the press release (Exhibit 99.1) for any additional context on future board appointments or strategic shifts.
- Check subsequent filings for the appointment of new directors to fill the vacancies.